# Task #59 Production Closeout

Task #59 — Bounded Competitor Evidence Acquisition Foundation v1 — is fully merged, published, runtime-certified, reconciled, and ready to be treated as closed.

## Canonical implementation

- Issue: #75
- PR: #76
- exact tested PR head: `f5c2ed87cda413489bf324ed6037c8658188c279`
- application merge / certified release source: `d5c7471a4bc788d7b0dbd63720ebe3b5f532c1b1`
- certified release tree: `e4e57b7da4dcbfc6e2db3f93c701e5155c6773f3`
- PR CI #156: success
- post-merge main CI #157: success

## What Task #59 adds

Task #59 extends Task #58 with a bounded acquisition and persistence foundation while remaining default-off and non-autonomous.

The v1 contract includes:

- explicit configured competitor target allowlist; request bodies select only configured target IDs
- public-network / SSRF checks before every fetch hop
- same-host and path-bounded redirects
- HTTPS downgrade rejection
- strict timeout, redirect-count, response-size, and HTML content-type limits
- robots/policy gate
- transient extraction of structural signals only
- raw competitor title/meta/H1/body copy is not retained
- all observations normalized through Task #58
- deterministic UUID evidence IDs derived from site ID + Task #58 fingerprint
- migration-free idempotency through the existing `evidence` primary key and `ON CONFLICT (id) DO NOTHING`
- authenticated Task #59 route surface behind existing API auth, admin role enforcement, CSRF protection, and sensitive-mutation rate limiting
- no scheduler
- no autonomous worker
- no automatic opportunity/action/proposal/execution transition

Default runtime gates:

- `COMPETITOR_COLLECTION_ENABLED=false`
- `COMPETITOR_EVIDENCE_PERSISTENCE_ENABLED=false`
- configured competitor targets = `0`
- `PUBLIC_SITE_WRITES_ENABLED=false`
- `AI_PROPOSAL_GENERATION_ENABLED=false`
- Task #53/#54 provider dispatch disabled
- Task #53/#54 schedulers disabled
- Task #54 batch execution disabled

## Engineering certification

Before publication:

- GitHub/Replit exact-synced to `d5c7471a4bc788d7b0dbd63720ebe3b5f532c1b1`
- tree `e4e57b7da4dcbfc6e2db3f93c701e5155c6773f3`
- ahead/behind `0/0`
- working tree clean
- Task #59 dedicated tests: `13/13` pass
- API typecheck: pass
- frontend typecheck: pass
- isolated API production build: pass
- isolated frontend production build: pass
- source and compiled safety markers verified
- development DB: 31 public base tables
- production DB: 31 public base tables
- Task #55 auth tables present in both
- all six Task #55 auth indexes present in both
- competitor evidence rows: 0 in development / 0 in production
- all pre/post operational counters unchanged
- no real competitor request, robots.txt request, acquisition route call, or database write occurred during certification

## Publication authorization and production certification

The user explicitly authorized publication of only certified canonical GitHub source `d5c7471a4bc788d7b0dbd63720ebe3b5f532c1b1`, while keeping competitor collection/persistence disabled and forbidding DDL, provider/public-site mutation, Task #53/#54 execution, scheduler/batch/autonomous-worker enablement, and secret/config/OAuth-scope changes.

Publication:

- existing Replit deployment ID: `fbef9788-c08d-475d-a85d-88ede16e92c7`
- production URL: `https://dsseoengine.replit.app`
- final publication status: success

Post-publication certification:

- `/api/healthz`: HTTP 200, status ok
- `/api/auth/status`: HTTP 200
- authentication configured and enforced
- provider: Google OIDC
- allowlist-only access enabled
- public registration disabled
- development/prod schema: 31/31 public base tables
- Task #55 auth tables present in both
- Task #55 auth indexes: 6/6 in both
- Task #59 collection: false
- Task #59 evidence persistence: false
- configured competitor targets: 0
- Task #59 scheduler: false
- Task #59 autonomous worker: false
- public-site writes: false
- AI proposals: false
- Task #53/#54 dispatch: false
- Task #53/#54 schedulers: false
- Task #54 batch: false
- evidence total unchanged: development 0 / production 922
- competitor evidence unchanged: development 0 / production 0
- action plans/actions/approvals/deployments/rollbacks/verifications/jobs: zero delta
- fatal/crash markers: none
- PostgreSQL 42883 markers: none
- unsafe mutation/execution markers: none
- scheduler/batch activity markers: none
- provider/public-site write markers: none
- unexpected Task #59 acquisition/collection/persistence/robots activity: none

Transient deployment healthcheck 500 responses occurred only during process startup before the API port became ready. Initialization completed normally and the live health endpoint returned HTTP 200 afterward.

## Replit publication drift reconciliation

Publication created one local-only empty metadata commit:

- SHA: `154edfe5643778395571653e09b6918f8c7d2546`
- subject: `Published your App`
- parent: canonical source `d5c7471a4bc788d7b0dbd63720ebe3b5f532c1b1`
- changed files: 0
- tree: `e4e57b7da4dcbfc6e2db3f93c701e5155c6773f3`, exactly equal to the canonical parent tree

The metadata-only commit was removed without republishing.

Final reconciled Replit state before this documentation closeout:

- branch `main`
- HEAD `d5c7471a4bc788d7b0dbd63720ebe3b5f532c1b1`
- tree `e4e57b7da4dcbfc6e2db3f93c701e5155c6773f3`
- `origin/main`: same
- GitHub `main`: same
- ahead/behind `0/0`
- tracked changes: 0
- untracked files: 0
- working tree clean
- no second publish occurred during reconciliation

## Authorization boundary after Task #59

Task #59 being live does **not** authorize actual competitor collection or evidence persistence. Those runtime gates remain closed. A generic `continue` permits safe engineering/documentation only.

The next milestone is Task #60 — Competitor Discovery + Collection Planning Foundation. Its safe first phase should discover and rank candidate competitor domains/pages or convert user-supplied candidates into deterministic collection plans without making external competitor requests, persisting competitor evidence, scheduling autonomous collection, or creating execution actions.

Any future real competitor network collection or production evidence persistence remains a separate explicit runtime authorization boundary.